A diagnosis of premature ovarian insufficiency often comes with a swift recommendation: consider donor eggs. For some patients, that message arrives after a single consultation and a blood test. It can feel like the door to parenthood with your own genetic material has closed before you have had the chance to fully understand what POI actually is — or whether all options have truly been explored.

At Hanabusa IVF, we specialize in complex fertility cases including premature ovarian insufficiency. Our position is that donor egg is a legitimate and often excellent path — but it should not be the automatic first recommendation before an adequate evaluation has been completed. For a meaningful subset of patients with POI, own-egg treatment options remain worth exploring.

What Is Premature Ovarian Insufficiency?

Premature ovarian insufficiency (POI) is a condition in which the ovaries stop functioning normally before age 40. The hallmarks include reduced estrogen production, elevated FSH, and irregular or absent periods. POI is sometimes called premature ovarian failure or premature menopause, but these terms are not entirely accurate.

POI Is Not the Same as Menopause

Menopause is defined by the permanent cessation of ovarian function. POI is different: the ovaries may still function intermittently. Research suggests that approximately 5–10% of patients with a confirmed POI diagnosis experience spontaneous ovulation and that a small but meaningful number conceive naturally. Intermittent ovarian activity is one of the key clinical reasons why POI does not automatically foreclose own-egg treatment.

POI Exists on a Spectrum

A 36-year-old with recently diagnosed POI and some residual follicular activity is in a fundamentally different biological position than a 26-year-old with complete ovarian quiescence. The recommendation should reflect that difference — which is why thorough evaluation before any treatment decision is essential.

"Not every patient with a POI diagnosis is in the same place biologically. Before we close any door, I want to understand where this patient actually is right now — her antral follicle count today, her FSH trend, whether there is any residual activity. That evaluation is the starting point, not the end point."

— Dr. Diana LeBlanc, a Fertility Specialist at Hanabusa IVF

Evaluating POI Before Making Treatment Decisions

At Hanabusa IVF, the evaluation for POI patients is more detailed than a single FSH and AMH draw. Before any treatment recommendation is made, the team reviews:

• Serial AMH and FSH measurements across multiple cycles to assess trend and variability
• Transvaginal ultrasound for antral follicle count (AFC) — even a few visible follicles changes the clinical picture
• Estradiol levels to assess whether any baseline ovarian activity remains
• Age at diagnosis and underlying cause of POI (autoimmune, genetic, iatrogenic, idiopathic)
• How long POI has been established and whether any spontaneous cycles have occurred recently

This comprehensive fertility evaluation provides the data needed to determine whether own-egg treatment is biologically plausible — or whether donor eggs offer the most realistic path to parenthood.

Own-Egg Treatment Options for POI Patients With Residual Activity

For patients with POI who still have detectable follicular activity, the following treatment approaches may be considered at Hanabusa IVF based on individual evaluation:

Natural Cycle IVF

Natural cycle IVF retrieves the single egg that develops spontaneously in a given cycle, without stimulation medications. For POI patients who still ovulate occasionally, intensive monitoring can identify these windows and time a retrieval accordingly. The approach works with the body's natural function rather than trying to override a system with limited reserve.

Minimal Stimulation IVF (Mini IVF)

Mini IVF uses lower doses of stimulation medications, working with the ovaries' residual capacity rather than against it. For some POI patients, gentle stimulation can encourage follicular development in a way that high-dose protocols cannot, since ovarian stress can actually suppress what little activity remains.

Modified Stimulation Protocols

Hanabusa IVF evaluates modified protocol approaches — including changes in medication type, sequencing, and timing — based on each patient's specific hormone profile, prior response history, and the cause of their POI. There is no universal protocol for POI, and the design is based on the individual's data.

Luteal Phase Stimulation

For patients with severely limited reserve, stimulation in the luteal phase (after ovulation) rather than the conventional follicular phase is an approach explored at specialized fertility centers. A new cohort of early follicles is present after ovulation and may be accessible in cycles where follicular-phase stimulation has not been productive.

"POI patients often feel like they have run out of options before they have actually explored them. My approach is to map what is biologically possible for this patient right now — and design a strategy around that reality, not around a textbook case."

— Dr. Lyndon Chang, Medical Director at Hanabusa IVF

Hormonal Support and Monitoring in POI Management

For POI patients, hormonal support — typically estrogen and progesterone — is important for long-term bone and cardiovascular health, not only for fertility. In a fertility context, hormonal priming may be used to create a more receptive environment for follicular development prior to a cycle.

Ongoing monitoring with ultrasound and blood work allows the team to watch for spontaneous follicular activity and act when a viable window presents. For POI patients pursuing own-egg treatment, this close monitoring is the foundation of the strategy.

When Donor Eggs Are the Right Answer

For patients with POI who have no detectable follicular activity, profoundly elevated and non-fluctuating FSH, no response to stimulation across multiple attempts, or who are ready to move forward without further delay — donor egg IVF is the most effective path and offers consistently high success rates.

Choosing donor eggs is not giving up. At Hanabusa IVF, the goal is to ensure that when patients make this decision, they are doing so with complete information — not because they were redirected before adequate evaluation was completed.

Frequently Asked Questions About POI Treatment

Can I still have a baby with my own eggs if I have POI?

For some patients with POI — particularly those with residual follicular activity — own-egg treatment remains a possibility. Success rates are lower than for patients without POI, and the approach requires individualized evaluation and close monitoring. A consultation at Hanabusa IVF can clarify what your specific situation suggests.

How do I know if I have any remaining ovarian activity with POI?

Residual activity is assessed through serial blood work (FSH, AMH, estradiol) and transvaginal ultrasound to count antral follicles across more than one cycle. Some patients show no detectable follicles consistently; others show intermittent activity. This variability is what makes serial evaluation more informative than a single test.

Is natural cycle IVF appropriate for POI?

For POI patients who still occasionally ovulate, natural cycle IVF allows retrieval of a spontaneously developing egg without the ovarian stress of stimulation. It requires intensive monitoring and careful timing. Whether it is appropriate depends on the degree of residual ovarian activity and the patient's full clinical picture.

Does HRT or hormonal support help fertility with POI?

Hormonal support is important for long-term health in POI patients and may be part of treatment cycle preparation, but it is not itself a fertility treatment for own-egg conception. It can prepare the uterine environment for embryo transfer in donor egg cycles. Its role in improving own-egg outcomes is limited.

What should I ask a fertility clinic if I have POI?

Ask about their specific experience with POI patients, whether they assess for residual follicular activity before recommending donor eggs, whether natural cycle or minimal stimulation options are available, and how they monitor for spontaneous follicular windows. These questions help distinguish individualized care from a standard approach.

POI Is the Beginning of an Evaluation — Not the End of Your Options

At Hanabusa IVF, a POI diagnosis opens a thorough conversation — not a form letter pointing toward donor eggs. For patients with any residual ovarian function, we explore what that function makes possible. For patients where own-egg treatment is not biologically feasible, we help them understand the donor egg path clearly and with full support.

If you have been diagnosed with POI and want to understand all of your options before making any decisions, we invite you to schedule a consultation at Hanabusa IVF.

Book Your Consultation at Hanabusa IVF

‍